Avantor, Inc. (AVTR): Price and Financial Metrics
Avantor, Inc. (AVTR)
Today's Latest Price: $17.53 USD
Updated Jul 2 7:00pm
Add AVTR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 33 in Consumer Goods
See all "A" rated Strong Buy stocks
AVTR Stock Summary
- AVTR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.31 -- higher than just 5.51% of US-listed equities with positive expected earnings growth.
- AVTR's went public 1.13 years ago, making it older than merely 0.74% of listed US stocks we're tracking.
- With a year-over-year growth in debt of -25.59%, Avantor Inc's debt growth rate surpasses just 11.36% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Avantor Inc are AWI, PKG, VSLR, POST, and RILY.
- Visit AVTR's SEC page to see the company's official filings. To visit the company's web site, go to www.avantorsciences.com.
AVTR Stock Price Chart Technical Analysis Charts
AVTR Price/Volume Stats
| Current price | $17.53 | 52-week high | $19.50 |
| Prev. close | $16.99 | 52-week low | $6.66 |
| Day low | $17.17 | Volume | 5,590,408 |
| Day high | $17.87 | Avg. volume | 3,641,355 |
| 50-day MA | $17.23 | Dividend yield | N/A |
| 200-day MA | $16.04 | Market Cap | 10.08B |
Avantor, Inc. (AVTR) Company Bio
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
AVTR Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $17.53 | $1322.12 | 7789% |
Below please find a table outlining a discounted cash flow forecast for AVTR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Avantor Inc ranked in the 96th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Avantor Inc, consider:
- The company's compound free cash flow growth rate over the past 0.99 years comes in at 1.98%; that's greater than 95.81% of US stocks we're applying DCF forecasting to.
- As a business, Avantor Inc experienced a tax rate of about 2% over the past twelve months; relative to its sector (Basic Materials), this tax rate is higher than merely 20.25% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 7634% |
| 1% | 7711% |
| 2% | 7789% |
| 3% | 7866% |
| 4% | 7943% |
| 5% | 8021% |
FUL, BTG, DOW, ITP, and FRTA can be thought of as valuation peers to AVTR, in the sense that they are in the Basic Materials sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...